Testosterone boost may help men with lung disease

	Tweet

Men with chronic obstructive pulmonary disease (COPD)—which includes a number of lung problems such as emphysema that make breathing difficult—may benefit from an extra dose of testosterone, a new study indicates.

People with COPD are often easily fatigued and can’t tolerate much physical exertion, probably because of loss of muscle strength.

Testosterone supplementation appears to increase lean muscle mass and strength in men with moderate to severe COPD and low testosterone levels, California-based researchers report in the American Journal of Respiratory and Critical Care Medicine.

“Patients with chronic lung disease have been found to benefit from rehabilitative therapies aimed at improving the function of their muscles. This research suggests the anabolic drug testosterone improves muscle strength,” Dr. Richard Casaburi told Reuters Health.

Casaburi of the Los Angeles Biomedical Research Institute, Torrance, and colleagues investigated the effects of testosterone supplementation in a study of 47 men with COPD and low normal testosterone levels.

The participants were randomly assigned to one of four treatment groups: testosterone supplementation and strength training; placebo and strength training; testosterone and no strength training; or placebo and no strength training.

After 10 weeks, both testosterone groups showed a significant increase in lean body mass. This amounted to an average increase of 2.3 kilograms (about 5 pounds) in those given testosterone alone and 3.3 kg (a little more than 7 pounds) in those who received training and testosterone.

Moreover, the team found that maximum leg press strength increased 17 percent with either testosterone alone or training alone, but by 27 percent with both. No adverse effects were seen.

Despite these encouraging results, “further research in a larger number of patients is needed before we can routinely recommend testosterone supplementation for men with COPD,” Casaburi cautioned.

SOURCE: American Journal of Respiratory and Critical Care Medicine, October 15, 2004.

RELATED STORIES:
Statins reduce deaths from infection and respiratory illness, 8 years on from trial   Obesity may boost pneumonia risk in men   Lung infections late problem for tsunami survivors   Statins May Increase Risk of Interstitial Lung Abnormalities in Smokers   Quitting Smoking Improves Lung Function Considerably   Underweight COPD patients at higher risk of death   Air travel may be risky for lung disease patients   Mouth Breathing Can Cause Major Health Problems   Childhood Respiratory Disease Boosts Illness and Death Risks in Adulthood   Sleep apnea ups risk of sudden death at night   Black lung disease seen rising in U.S. miners   Genetic Factors in Smoking Also Increase Risk of Chronic Bronchitis

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]